[HTML][HTML] PET/MRI in prostate cancer: a systematic review and meta-analysis

L Evangelista, F Zattoni, G Cassarino, P Artioli… - European journal of …, 2021 - Springer
Aim In recent years, the clinical availability of scanners for integrated positron emission
tomography (PET) and magnetic resonance imaging (MRI) has enabled the practical …

Can negative prostate-specific membrane antigen positron emission tomography/computed tomography avoid the need for pelvic lymph node dissection in newly …

A Stabile, A Pellegrino, E Mazzone… - European Urology …, 2022 - Elsevier
Context The role of positron emission tomography/computed tomography (PET/CT) with
prostate-specific membrane antigen (PSMA) in the primary staging for patients with prostate …

Optimum imaging strategies for advanced prostate cancer: ASCO guideline

EJ Trabulsi, RB Rumble, H Jadvar, T Hope… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Provide evidence-and expert-based recommendations for optimal use of
imaging in advanced prostate cancer. Due to increases in research and utilization of novel …

[HTML][HTML] Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI

L Papp, CP Spielvogel, B Grubmüller… - European journal of …, 2021 - Springer
Purpose Risk classification of primary prostate cancer in clinical routine is mainly based on
prostate-specific antigen (PSA) levels, Gleason scores from biopsy samples, and tumor …

Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with a histopathology gold standard in the detection, intraprostatic localization, and determination of …

I Sonni, ER Felker, AT Lenis, AE Sisk… - Journal of Nuclear …, 2022 - Soc Nuclear Med
The role of prostate-specific membrane antigen (PSMA)–targeted PET in comparison to
multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well …

Using PSMA imaging for prognostication in localized and advanced prostate cancer

MJ Roberts, T Maurer, M Perera, M Eiber… - Nature Reviews …, 2023 - nature.com
The use of prostate-specific membrane antigen (PSMA)-directed applications in modern
prostate cancer management has evolved rapidly over the past few years, helping to …

[HTML][HTML] Diagnostic performance of prostate-specific membrane antigen positron emission tomography–targeted biopsy for detection of clinically significant prostate …

T Kawada, T Yanagisawa, P Rajwa, RS Motlagh… - European urology …, 2022 - Elsevier
Context Prostate-specific membrane antigen positron emission tomography (PSMA-PET)
has gained acceptance as a staging tool for prostate cancer (PCa). Recent reports suggest …

Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings: a prospective single-center study

I Sonni, M Eiber, WP Fendler, RM Alano… - Journal of Nuclear …, 2020 - Soc Nuclear Med
The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …

[HTML][HTML] Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate …

B Grubmüller, D Senn, G Kramer, P Baltzer… - European journal of …, 2019 - Springer
Purpose The first aim of this study was to evaluate 68 Ga-PSMA HBED-CC conjugate 11
positron emission tomography (PSMA PET) parameters for assessment of response to 177 …

[HTML][HTML] Role of peptides in diagnostics

S Pandey, G Malviya… - International Journal of …, 2021 - mdpi.com
The specificity of a diagnostic assay depends upon the purity of the biomolecules used as a
probe. To get specific and accurate information of a disease, the use of synthetic peptides in …